Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
yKpVfw3FyRhYfG98
